These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 26773504)

  • 41. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ly6/uPAR-related protein C4.4A as a marker of solid growth pattern and poor prognosis in lung adenocarcinoma.
    Jacobsen B; Muley T; Meister M; Dienemann H; Christensen IJ; Santoni-Rugiu E; Lærum OD; Ploug M
    J Thorac Oncol; 2013 Feb; 8(2):152-60. PubMed ID: 23287851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis.
    Zhang PF; Zeng GQ; Hu R; Li C; Yi H; Li MY; Li XH; Qu JQ; Wan XX; He QY; Li JH; Chen Y; Ye X; Li JY; Wang YY; Feng XP; Xiao ZQ
    J Proteomics; 2012 Dec; 77():202-14. PubMed ID: 22982323
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of integrin β1 as a prognostic biomarker for human lung adenocarcinoma using 2D-LC-MS/MS combined with iTRAQ technology.
    Zhang PF; Zeng GQ; Yi LZ; Liu JP; Wan XX; Qu JQ; Li JH; Li C; Tang CE; Hu R; Ye X; Chen Y; Chen ZC; Xiao ZQ
    Oncol Rep; 2013 Jul; 30(1):341-9. PubMed ID: 23677397
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SOX30 specially prevents Wnt-signaling to suppress metastasis and improve prognosis of lung adenocarcinoma patients.
    Han F; Zhang MQ; Liu WB; Sun L; Hao XL; Yin L; Jiang X; Cao J; Liu JY
    Respir Res; 2018 Dec; 19(1):241. PubMed ID: 30514297
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1.
    Hsu EC; Rice MA; Bermudez A; Marques FJG; Aslan M; Liu S; Ghoochani A; Zhang CA; Chen YS; Zlitni A; Kumar S; Nolley R; Habte F; Shen M; Koul K; Peehl DM; Zoubeidi A; Gambhir SS; Kunder CA; Pitteri SJ; Brooks JD; Stoyanova T
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2032-2042. PubMed ID: 31932422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neural Wiskott-Aldrich syndrome protein (nWASP) is implicated in human lung cancer invasion.
    Frugtniet BA; Martin TA; Zhang L; Jiang WG
    BMC Cancer; 2017 Mar; 17(1):224. PubMed ID: 28351346
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
    Zhang Z; Guo Y
    Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Expression of TROP2 mRNA in left-sided and right-sided colon cancer and its clinical significance].
    Xu KY; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):285-9. PubMed ID: 19434540
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways.
    Guan H; Guo Z; Liang W; Li H; Wei G; Xu L; Xiao H; Li Y
    BMC Cancer; 2017 Jul; 17(1):486. PubMed ID: 28709407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
    Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
    Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANCCA protein expression is a novel independent poor prognostic marker in surgically resected lung adenocarcinoma.
    Zhang Y; Sun Y; Li Y; Fang Z; Wang R; Pan Y; Hu H; Luo X; Ye T; Li H; Wang L; Chen H; Ji H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S577-82. PubMed ID: 23775406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulator of G-protein signaling 4: A novel tumor suppressor with prognostic significance in non-small cell lung cancer.
    Cheng C; Yue W; Li L; Li S; Gao C; Si L; Tian H
    Biochem Biophys Res Commun; 2016 Jan; 469(3):384-91. PubMed ID: 26640232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
    Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
    World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histone deacetylase 5 promotes the proliferation and invasion of lung cancer cells.
    Zhong L; Sun S; Yao S; Han X; Gu M; Shi J
    Oncol Rep; 2018 Oct; 40(4):2224-2232. PubMed ID: 30066893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overexpression of astrocyte-elevated gene-1 is closely correlated with poor prognosis in human non-small cell lung cancer and mediates its metastasis through up-regulation of matrix metalloproteinase-9 expression.
    Sun S; Ke Z; Wang F; Li S; Chen W; Han A; Wang Z; Shi H; Wang LT; Chen X
    Hum Pathol; 2012 Jul; 43(7):1051-60. PubMed ID: 22204714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer.
    Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J
    Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.